Use of [(18)F]Fluoro-2-deoxy-d-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial.

ABSTRACT:

Background

Positron emission tomography (PET) is a diagnostic tool for lung cancer evaluation. No studies have ascertained practice patterns and determined the appropriateness of PET imaging in a large group of US patients with screen-detected lung nodules.

Methods

We analyzed participants in the National Lung Screening Trial (NLST) with positive screening test results and identified individuals with a PET scan performed prior to lung cancer diagnosis (diagnostic PET). Appropriate scan was defined as one performed in a patient with a nodule ≥ 0.8 cm. Logistic regression was used to assess factors associated with diagnostic PET scan use and appropriateness of PET scan use.

Results

Diagnostic PET imaging was performed in 1,556 of 14,195 patients (11%) with positive scre

SUBMITTER: Nair VS 

PROVIDER: S-EPMC6026233 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature